subject
Chemistry, 19.03.2021 18:10 f1a4n6ny

Structure-based drug design strategies often devise competitive Inhibitors that bind to certain enzyme active sites. For example saquinavir and Indinavir are designed HIV protease inhibitors that bind to the aspartate protease enzyme of HIV, which is required for the virus to produce functional proteins for further HIV infection. Which of the following statements are true about saquinavir and Indinavir? Choose one or more:
A. Very high local concentrations of proteins with Phe-Pro or Tyr-Pro peptide bonds would reduce the protease enzyme reaction vir and indinavir both have a component that mimics the natural Phe-Pro dipeptide substrate of aspartate
B. The removal of the phenyi ring (six-membered carbon ring containing three double bonds and no attached functional groups) on indinavir and saquinavir would likely affect their Inhibitory activity
C. Increasing concentrations of indinavir or saquinavir would result in a change in the a of the aspartate
D. Saquinav effectiveness of saquinavir and indinavir in limiting HiV's infectivity of new cells. protease enzyme reaction vir and indinavir both have a component that mimics the natural Phe-Pro dipeptide substrate of aspartate

ansver
Answers: 2

Another question on Chemistry

question
Chemistry, 22.06.2019 10:00
Why is the structure of molecule important to its function?
Answers: 1
question
Chemistry, 22.06.2019 11:20
Sodium nitrite (nano2) reacted with 2−iodooctane to give a mixture of two constitutionally isomeric compounds of molecular formula c8h17no2 in a combined yield of 88%. draw reasonable structures for these two isomers. click the "draw structure" button to launch the drawing utility. place the two compounds in the appropriate boxes below.
Answers: 1
question
Chemistry, 23.06.2019 06:30
An engineer decides to use a slightly weaker material rather than a stronger material, since she knows that the stronger material can break suddenly. this is an example of what? a choosing a material that will show warning before it fails b using composite materials that combine strength c using a material for multiple applications d using design techniques that increase efficiency and reduce cost
Answers: 3
question
Chemistry, 23.06.2019 07:30
Achemist at a pharmaceutical company is measuring equilibrium constants for reactions in which drug candidate molecules bind to a protein involved in cancer. the drug molecules bind the protein in a 1: 1 ratio to form a drug-protein complex. the protein concentration in aqueous solution at 25 Ëšc is 1.74 x10-6 m . drug a is introduced into the protein solution at an initial concentration of 2.00 x10-6m. drug b is introduced into a separate, identical protein solution at an initial concentration of 2.00 x10-6m. at equilibrium, the drug a-protein solution has an a-protein complex concentration of 1.00 x10-6m, and the drug b solution has a b-protein complex concentration of 1.40 x10-6m.a. calculate the kc value for the a-protein binding reaction.b. calculate the kc value for the b-protein binding reaction.c. assuming that the drug that binds more strongly will be more effective, which drug is the better choice for further research?
Answers: 1
You know the right answer?
Structure-based drug design strategies often devise competitive Inhibitors that bind to certain enzy...
Questions
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00
question
Mathematics, 03.12.2020 04:00